Centerbridge Partners’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Centerbridge Partners’s Portfolio DRTSW Stock Details DRTSW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$24K	–	35
2022 Q2	$24K	Hold	50,000	–	–	﹤0.01%	17
2022 Q1	$305K	Buy	+50,000	New	+$27.3K	0.02%	15

Other funds holding DRTSW

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

Corbin Capital Partners New York $61.3M AUM 53.03% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Centerbridge Partners's DRTSW Position: Q3 2022 in Review

Centerbridge Partners sold out of Alpha Tau Medical Warrant (DRTSW) in Q3 2022, closing a stake of 50,000 shares — an estimated $24K sold.

Centerbridge Partners first reported a position in DRTSW in Q1 2022 and held it in 2 quarters. The position peaked at $305K in Q1 2022. 38 funds tracked by Wall St. Rank hold DRTSW as of Q3 2022.

Centerbridge Partners reported no remaining Alpha Tau Medical Warrant position as of Q3 2022 after selling out during the quarter.
Centerbridge Partners sold 50,000 Alpha Tau Medical Warrant shares in Q3 2022, an estimated $24K.
Centerbridge Partners first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 2 quarters.
Centerbridge Partners's Alpha Tau Medical Warrant position peaked at $305K in Q1 2022.
38 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q3 2022.

Based on Centerbridge Partners's 13F filing for Q3 2022, filed 14 Nov 2022.